Article(id=1322125562760507426, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322125552731927464, articleNumber=null, orderNo=null, doi=null, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=1610553600000, acceptedDateStr=2021-01-14, onlineDate=1793148898067, onlineDateStr=2026-10-28, pubDate=1638201600000, pubDateStr=2021-11-30, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793148898067, onlineIssueDateStr=2026-10-28, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793148898067, creator=13701087609, updateTime=1793148898067, updator=13701087609, issue=Issue{id=1322125552731927464, tenantId=1146029695717560320, journalId=1235980733773295621, year='2021', volume='30', issue='22', pageStart='2017', pageEnd='2120', issueExtLink='null', onlineDate='null', pubDate='1638201600000', pubDateStr='2021-11-30', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793148895675, creator='13701087609', updateTime=1793149501548, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1322128094022971944, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322125552731927464, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1322128094022971945, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322125552731927464, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=2049, endPage=2052, ext={EN=ArticleExt(id=1322125563079274531, articleId=1322125562760507426, tenantId=1146029695717560320, journalId=1235980733773295621, language=EN, title=Ubrogepant: an oral new drug against migraine, columnId=null, journalTitle=Chinese Journal of New Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=

Ubrogepant is a small-molecule oral potent calcitonin gene-related peptide receptor antagonist. It was approved by the U. S. FDA for the treatment of migraine on December 23, 2019. The approval of ubrogepant represents the first major innovation in the treatment of acute migraine in the past 25 years. This paper reviews the mechanism of action, pharmacokinetics, pharmacodynamics, clinical studies and safety evaluation of the drug.

, authors=Ya-nan WANG1, Wei WEI2, Yi HONG1, authorsList=Ya-nan WANG, Wei WEI, Yi HONG, authorCompany=null, correspAuthors=Yi HONG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1322125563343515684, articleId=1322125562760507426, tenantId=1146029695717560320, journalId=1235980733773295621, language=CN, title=治疗偏头痛的口服新药ubrogepant, columnId=1236331162679955859, journalTitle=中国新药杂志, columnName=新药述评与论坛, runingTitle=null, highlight=null, articleAbstract=

ubrogepant是一种小分子口服的强效降钙素基因相关肽受体拮抗剂,该药于2019年12月23日被美国FDA批准上市,用于偏头痛的治疗。此次批准意味着25年来急性偏头痛治疗的首个重大创新。本文对该药物的作用机制、药动学、药效学、临床研究、安全性评价等进行评述。

, authors=王亚楠1, 魏威2, 洪怡1, authorsList=王亚楠, 魏威, 洪怡, authorCompany=null, correspAuthors=洪怡, authorNote=

王亚楠,女,本科生,研究方向:制剂新技术与新剂型。E-mail:。

, correspAuthorsNote=
洪怡,女,博士,副教授,主要从事药物制剂新技术与新药研发。E-mail:。
, copyrightStatement=null, copyrightOwner=《中国新药杂志》有限公司, extLink=null, articleAbsUrl=null, sourceXml=2K+l6vQbeK4S6zzLTPmMKA==, magXml=FsQEv/gka3nJNvfoRj4r+w==, pdfUrl=null, pdf=0ptdFj6MQzcGlXE7f5OpCg==, pdfFileSize=799343, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=wwnRvwmTviqdM4j/PUnx6w==, mapNumber=null, fund=null)}, authors=[Author(id=1322125563741974572, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=2142748311@qq.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322125563834249262, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, authorId=1322125563741974572, language=EN, stringName=Ya-nan WANG, firstName=Ya-nan, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1Pharmacy Faculty, Hubei University of Chinese Medicine, Wuhan 430065, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322125563913941039, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, authorId=1322125563741974572, language=CN, stringName=王亚楠, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1湖北中医药大学药学院,武汉 430065, bio={"content":"

王亚楠,女,本科生,研究方向:制剂新技术与新剂型。E-mail:。

"}, bioImg=null, bioContent=

王亚楠,女,本科生,研究方向:制剂新技术与新剂型。E-mail:。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322125563544842277, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, xref=1, ext=[AuthorCompanyExt(id=1322125563553230886, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, companyId=1322125563544842277, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1Pharmacy Faculty, Hubei University of Chinese Medicine, Wuhan 430065, China), AuthorCompanyExt(id=1322125563565813799, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, companyId=1322125563544842277, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1湖北中医药大学药学院,武汉 430065)])]), Author(id=1322125564014604337, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322125564127850547, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, authorId=1322125564014604337, language=EN, stringName=Wei WEI, firstName=Wei, middleName=null, lastName=WEI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2Beijing Baron Medical Equipment Co., Ltd., Beijing 100176, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322125564199153716, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, authorId=1322125564014604337, language=CN, stringName=魏威, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2北京巴瑞医疗器械有限公司,北京 100176, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322125563653894184, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, xref=2, ext=[AuthorCompanyExt(id=1322125563662282793, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, companyId=1322125563653894184, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2Beijing Baron Medical Equipment Co., Ltd., Beijing 100176, China), AuthorCompanyExt(id=1322125563670671402, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, companyId=1322125563653894184, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2北京巴瑞医疗器械有限公司,北京 100176)])]), Author(id=1322125564278845494, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=46447564@qq.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1322125564375314488, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, authorId=1322125564278845494, language=EN, stringName=Yi HONG, firstName=Yi, middleName=null, lastName=HONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1Pharmacy Faculty, Hubei University of Chinese Medicine, Wuhan 430065, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322125564446617657, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, authorId=1322125564278845494, language=CN, stringName=洪怡, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1湖北中医药大学药学院,武汉 430065, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322125563544842277, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, xref=1, ext=[AuthorCompanyExt(id=1322125563553230886, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, companyId=1322125563544842277, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1Pharmacy Faculty, Hubei University of Chinese Medicine, Wuhan 430065, China), AuthorCompanyExt(id=1322125563565813799, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, companyId=1322125563544842277, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1湖北中医药大学药学院,武汉 430065)])])], keywords=[Keyword(id=1322125564564058170, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, language=EN, orderNo=1, keyword=ubrogepant), Keyword(id=1322125564647944251, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, language=EN, orderNo=2, keyword=small molecule), Keyword(id=1322125564723441724, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, language=EN, orderNo=3, keyword=calcitonin gene-related peptide receptor antagonist), Keyword(id=1322125564790550589, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, language=EN, orderNo=4, keyword=migraine), Keyword(id=1322125564861853758, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, language=CN, orderNo=1, keyword=ubrogepant), Keyword(id=1322125564924768319, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, language=CN, orderNo=2, keyword=小分子), Keyword(id=1322125564991877184, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, language=CN, orderNo=3, keyword=降钙素基因相关肽受体拮抗剂), Keyword(id=1322125565054791745, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, language=CN, orderNo=4, keyword=偏头痛)], refs=[Reference(id=1322125565147066434, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=MANZONI GC, STOVNER LJ. Epidemiology of headache[J]. Handbook Clin Neurol, 2010, 97(10): 3-22., articleTitle=null, refAbstract=null), Reference(id=1322125565226758211, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=DODICK DW, SILBERSTEIN SD. Migraine prevention[J]. Pract Neurol, 2007, 7(6): 383-393., articleTitle=null, refAbstract=null), Reference(id=1322125565306449988, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=SILBERSTEIN SD. Emerging target-based paradigms to prevent and treat migraine[J]. Clin Pharmacol Ther, 2013, 93(1): 78-85., articleTitle=null, refAbstract=null), Reference(id=1322125565377753157, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=张兵帅, 李博文, 邱智东, 等. 偏头痛研究进展[J]. 亚太传统医药, 2017, 13(22): 43-45., articleTitle=null, refAbstract=null), Reference(id=1322125565449056326, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=于生元, 陈敏. 成人偏头痛的药物治疗策略[J]. 中国新药杂志, 2014, 23(14): 1631-1636., articleTitle=null, refAbstract=null), Reference(id=1322125565532942407, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=SCHUSTER NM, RAPOPORT AM. Calcitonin gene-related peptide-targeted therapies for migraine and cluster headache: a review[J]. Clin Neuropharmacol, 2017, 40(4): 169-174., articleTitle=null, refAbstract=null), Reference(id=1322125565600051272, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=GOADSBY PJ, HOLLAND PR, MARTINS-OLIVEIRA M, et al. Pathophysiology of migraine: a disorder of sensory processing[J]. Physiol Rev, 2017, 97(2): 553-622., articleTitle=null, refAbstract=null), Reference(id=1322125565688131657, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=PIETROBON D, MOSKOWITZ MA. Pathophysiology of migraine[J]. Ann Rev Physiol, 2013, 75(1): 365-391., articleTitle=null, refAbstract=null), Reference(id=1322125565759434826, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=RADDANT AC, RUSSO AF. Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation[J]. Exp Rev Mol Med, 2011, 13: e36., articleTitle=null, refAbstract=null), Reference(id=1322125565826543691, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=HAY DL. What makes a CGRP2 receptor?[J]. Clin Exp Pharmacol Physiol, 2007, 34(10): 963-971., articleTitle=null, refAbstract=null), Reference(id=1322125565893652556, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=LI X, HU C, WU W, et al. Inhibitory effect of calcitonin gene-related peptide on hypoxia-induced rat pulmonary artery smooth muscle cells proliferation: role of ERK1/2 and p27[J]. Eur J Pharmacol, 2012, 679(1-3): 117-126., articleTitle=null, refAbstract=null), Reference(id=1322125565981732941, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=EVANGELISTA S. Role of calcitonin gene-related Peptide in gastric mucosal defence and healing[J]. Curr Pharmaceutical Des, 2009, 15(30): 3571-3576., articleTitle=null, refAbstract=null), Reference(id=1322125566061424718, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=尹优聪, 李元建. 降钙素基因相关肽介导的药物药理学效应[J]. 中国药理学与毒理学杂志, 2017, 31(1): 112-118., articleTitle=null, refAbstract=null), Reference(id=1322125566157893711, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=CLARIVATE ANALYTICS. Clarivate Analytics Cortellis数据库[EB/OL]. (2019-12-24) [2020-01-10]. https://www.cortellis.com/., articleTitle=null, refAbstract=null), Reference(id=1322125566245974096, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=ALLERGAN. UBRELVY (ubrogepant): US prescribing information[EB/OL]. (2019-12-23) [2020-01-13]. http://www.fda.gov., articleTitle=null, refAbstract=null), Reference(id=1322125566338248785, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=VOSS T, LIPTON RB, DODICK DW, et al. A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine[J]. Cephalalgia, 2016, 36(9): 887-898., articleTitle=null, refAbstract=null), Reference(id=1322125566409551954, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=GOADSBY PJ, TEPPER SJ, WATKINS PB, et al. Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults[J]. Cephalalgia, 2019, 39(14): 1753-1761., articleTitle=null, refAbstract=null), Reference(id=1322125566480855123, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=AILANI J, LIPTON RB, HUTCHINSON S, et al. Long-term safety evaluation of ubrogepant for the acute treatment of migraine: phase 3, randomized, 52-week extension trial[J]. Headache: J Head Face Pain, 2020, 60(1): 141-152., articleTitle=null, refAbstract=null), Reference(id=1322125566560546900, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=JAKATE A, BOINPALLY R, BUTLER M, et al. Evaluation of the pharmacokinetic interaction and safety of ubrogepant coadministered with acetaminophen or nonsteroidal anti-inflammatory drugs. A randomized trial[J]. Cephalalgia Reps, 2020, 3: 1-3., articleTitle=null, refAbstract=null), Reference(id=1322125566640238677, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=SCOTT LJ. Ubrogepant: first approval[J]. Drugs, 2020, 80(3): 323-328., articleTitle=null, refAbstract=null), Reference(id=1322125566703153238, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=DODICK DW, LIPTON RB, AILANI J, et al. Ubrogepant for the treatment of migraine[J]. N Engl J Med, 2019, 381(23): 2230-2241., articleTitle=null, refAbstract=null), Reference(id=1322125566824788055, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=LIPTON RB, DODICK DW, AILANI J, et al. Effect of ubrogepant vs placebo on pain and the most bothersome associated symptom in the acute treatment of migraine: the ACHIEVE II randomized clinical trial[J]. J Am Med Assoc, 2019, 322(19): 1887-1898., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1322125563544842277, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, xref=1, ext=[AuthorCompanyExt(id=1322125563553230886, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, companyId=1322125563544842277, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1Pharmacy Faculty, Hubei University of Chinese Medicine, Wuhan 430065, China), AuthorCompanyExt(id=1322125563565813799, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, companyId=1322125563544842277, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1湖北中医药大学药学院,武汉 430065)]), AuthorCompany(id=1322125563653894184, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, xref=2, ext=[AuthorCompanyExt(id=1322125563662282793, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, companyId=1322125563653894184, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2Beijing Baron Medical Equipment Co., Ltd., Beijing 100176, China), AuthorCompanyExt(id=1322125563670671402, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, companyId=1322125563653894184, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2北京巴瑞医疗器械有限公司,北京 100176)])], figs=null, attaches=null, journal=Journal(id=1235980159023624194, delFlag=0, nameCn=中国新药杂志, nameEn=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, issn=1003-3734, eissn=null, cn=11-2850/R, coden=ZXZHA6, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of New Drugs, journalRemark=null, publicationField=null, createdTime=1772610233314, updatedTime=1788948968376, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=ohPEEN//Vz1tDT3ZBNTp4Q==, picEn=f9WK9bvTM4guTmS/iGhOMg==, jcr=null, cjcr=null, exts=[JournalExt(id=1304509780974924039, language=CN, name=中国新药杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968404, updatedTime=1788948968404, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1304509781025255688, language=EN, name=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968416, updatedTime=1788948968416, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1235980733773295621, websiteList=[Website(id=1235982099191222761, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/CN, language=CN, createTime=1772610695884, createBy=18614031015, updateTime=1772610860397, updateBy=18614031015, name=中国新药杂志-中文, tplId=1146099689490845704, title=中国新药杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983918629966444, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=articleTextType, value=kx, createTime=1772611129672, updateTime=1772611129672, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918604800617, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=banner, value=null, createTime=1772611129666, updateTime=1772611129666, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918655132271, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=grayFlag, value=0, createTime=1772611129678, updateTime=1772611129678, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918596412008, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611129664, updateTime=1772611129664, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918667715185, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=minRunFlag, value=0, createTime=1772611129681, updateTime=1772611129681, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918617383531, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic, createTime=1772611129669, updateTime=1772611129669, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918659326576, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=silenceFlag, value=0, createTime=1772611129679, updateTime=1772611129679, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918613189226, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1772611129668, updateTime=1772611129668, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918634160749, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeColor, value=null, createTime=1772611129673, updateTime=1772611129673, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918646743662, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeStyle, value=null, createTime=1772611129676, updateTime=1772611129676, creator=18614031015, updator=18614031015)]), Website(id=1235982099270914542, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/EN, language=EN, createTime=1772610695903, createBy=18614031015, updateTime=1772610875891, updateBy=18614031015, name=中国新药杂志-英文, tplId=1146101810881728533, title=Chinese Journal of New Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983955829248630, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=articleTextType, value=kx, createTime=1772611138541, updateTime=1772611138541, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955804082803, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=banner, value=null, createTime=1772611138535, updateTime=1772611138535, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955854414457, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=grayFlag, value=0, createTime=1772611138547, updateTime=1772611138547, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955795694194, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611138533, updateTime=1772611138533, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955866997371, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=minRunFlag, value=0, createTime=1772611138550, updateTime=1772611138550, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955820860021, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic, createTime=1772611138539, updateTime=1772611138539, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955862803066, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=silenceFlag, value=0, createTime=1772611138549, updateTime=1772611138549, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955812471412, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1772611138537, updateTime=1772611138537, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955837637239, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeColor, value=null, createTime=1772611138543, updateTime=1772611138543, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955846025848, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeStyle, value=null, createTime=1772611138545, updateTime=1772611138545, creator=18614031015, updator=18614031015)])], journalTitle=中国新药杂志, weixinUrl=null, journalUrl=http://www.newdrug.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of New Drugs, journalPhotoCn=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPhotoEn=f9WK9bvTM4guTmS/iGhOMg==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/Y2021/V30/I22/2049, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/Y2021/V30/I22/2049, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/PDF/Y2021/V30/I22/2049, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/PDF/Y2021/V30/I22/2049, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1638201600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
治疗偏头痛的口服新药ubrogepant
收藏切换
PDF下载
王亚楠 1 , 魏威 2 , 洪怡 1
中国新药杂志 | 新药述评与论坛 2021,30(22): 2049-2052
收起
收藏切换
中国新药杂志 |新药述评与论坛 2021 , 30 (22) : 2049 -2052
治疗偏头痛的口服新药ubrogepant
全屏
[Author(id=1322125563741974572, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=2142748311@qq.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322125563834249262, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, authorId=1322125563741974572, language=EN, stringName=Ya-nan WANG, firstName=Ya-nan, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1Pharmacy Faculty, Hubei University of Chinese Medicine, Wuhan 430065, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322125563913941039, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, authorId=1322125563741974572, language=CN, stringName=王亚楠, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1湖北中医药大学药学院,武汉 430065, bio={"content":"

王亚楠,女,本科生,研究方向:制剂新技术与新剂型。E-mail:。

"}, bioImg=null, bioContent=

王亚楠,女,本科生,研究方向:制剂新技术与新剂型。E-mail:。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322125563544842277, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, xref=1, ext=[AuthorCompanyExt(id=1322125563553230886, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, companyId=1322125563544842277, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1Pharmacy Faculty, Hubei University of Chinese Medicine, Wuhan 430065, China), AuthorCompanyExt(id=1322125563565813799, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, companyId=1322125563544842277, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1湖北中医药大学药学院,武汉 430065)])]), Author(id=1322125564014604337, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322125564127850547, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, authorId=1322125564014604337, language=EN, stringName=Wei WEI, firstName=Wei, middleName=null, lastName=WEI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2Beijing Baron Medical Equipment Co., Ltd., Beijing 100176, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322125564199153716, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, authorId=1322125564014604337, language=CN, stringName=魏威, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2北京巴瑞医疗器械有限公司,北京 100176, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322125563653894184, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, xref=2, ext=[AuthorCompanyExt(id=1322125563662282793, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, companyId=1322125563653894184, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2Beijing Baron Medical Equipment Co., Ltd., Beijing 100176, China), AuthorCompanyExt(id=1322125563670671402, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, companyId=1322125563653894184, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2北京巴瑞医疗器械有限公司,北京 100176)])]), Author(id=1322125564278845494, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=46447564@qq.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1322125564375314488, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, authorId=1322125564278845494, language=EN, stringName=Yi HONG, firstName=Yi, middleName=null, lastName=HONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1Pharmacy Faculty, Hubei University of Chinese Medicine, Wuhan 430065, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322125564446617657, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, authorId=1322125564278845494, language=CN, stringName=洪怡, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1湖北中医药大学药学院,武汉 430065, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322125563544842277, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, xref=1, ext=[AuthorCompanyExt(id=1322125563553230886, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, companyId=1322125563544842277, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1Pharmacy Faculty, Hubei University of Chinese Medicine, Wuhan 430065, China), AuthorCompanyExt(id=1322125563565813799, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125562760507426, companyId=1322125563544842277, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1湖北中医药大学药学院,武汉 430065)])])]
王亚楠1 , 魏威2, 洪怡1
作者信息
  • 1湖北中医药大学药学院,武汉 430065
  • 2北京巴瑞医疗器械有限公司,北京 100176
通讯作者:
洪怡,女,博士,副教授,主要从事药物制剂新技术与新药研发。E-mail:。
作者简介:

王亚楠,女,本科生,研究方向:制剂新技术与新剂型。E-mail:。

Ubrogepant: an oral new drug against migraine
Ya-nan WANG1 , Wei WEI2, Yi HONG1
Affiliations
  • 1Pharmacy Faculty, Hubei University of Chinese Medicine, Wuhan 430065, China
  • 2Beijing Baron Medical Equipment Co., Ltd., Beijing 100176, China
出版时间: 2021-11-30
文章导航
收藏切换

ubrogepant是一种小分子口服的强效降钙素基因相关肽受体拮抗剂,该药于2019年12月23日被美国FDA批准上市,用于偏头痛的治疗。此次批准意味着25年来急性偏头痛治疗的首个重大创新。本文对该药物的作用机制、药动学、药效学、临床研究、安全性评价等进行评述。

ubrogepant  /  小分子  /  降钙素基因相关肽受体拮抗剂  /  偏头痛

Ubrogepant is a small-molecule oral potent calcitonin gene-related peptide receptor antagonist. It was approved by the U. S. FDA for the treatment of migraine on December 23, 2019. The approval of ubrogepant represents the first major innovation in the treatment of acute migraine in the past 25 years. This paper reviews the mechanism of action, pharmacokinetics, pharmacodynamics, clinical studies and safety evaluation of the drug.

ubrogepant  /  small molecule  /  calcitonin gene-related peptide receptor antagonist  /  migraine
王亚楠, 魏威, 洪怡. 治疗偏头痛的口服新药ubrogepant. 中国新药杂志, 2021 , 30 (22) : 2049 -2052 .
Ya-nan WANG, Wei WEI, Yi HONG. Ubrogepant: an oral new drug against migraine[J]. Chinese Journal of New Drugs, 2021 , 30 (22) : 2049 -2052 .

参考文献 引证文献
排序方式:
[1]
MANZONI GC, STOVNER LJ. Epidemiology of headache[J]. Handbook Clin Neurol, 2010, 97(10): 3-22.
[2]
DODICK DW, SILBERSTEIN SD. Migraine prevention[J]. Pract Neurol, 2007, 7(6): 383-393.
[3]
SILBERSTEIN SD. Emerging target-based paradigms to prevent and treat migraine[J]. Clin Pharmacol Ther, 2013, 93(1): 78-85.
[4]
张兵帅, 李博文, 邱智东, 等. 偏头痛研究进展[J]. 亚太传统医药, 2017, 13(22): 43-45.
[5]
于生元, 陈敏. 成人偏头痛的药物治疗策略[J]. 中国新药杂志, 2014, 23(14): 1631-1636.
[6]
SCHUSTER NM, RAPOPORT AM. Calcitonin gene-related peptide-targeted therapies for migraine and cluster headache: a review[J]. Clin Neuropharmacol, 2017, 40(4): 169-174.
[7]
GOADSBY PJ, HOLLAND PR, MARTINS-OLIVEIRA M, et al. Pathophysiology of migraine: a disorder of sensory processing[J]. Physiol Rev, 2017, 97(2): 553-622.
[8]
PIETROBON D, MOSKOWITZ MA. Pathophysiology of migraine[J]. Ann Rev Physiol, 2013, 75(1): 365-391.
[9]
RADDANT AC, RUSSO AF. Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation[J]. Exp Rev Mol Med, 2011, 13: e36.
[10]
HAY DL. What makes a CGRP2 receptor?[J]. Clin Exp Pharmacol Physiol, 2007, 34(10): 963-971.
[11]
LI X, HU C, WU W, et al. Inhibitory effect of calcitonin gene-related peptide on hypoxia-induced rat pulmonary artery smooth muscle cells proliferation: role of ERK1/2 and p27[J]. Eur J Pharmacol, 2012, 679(1-3): 117-126.
[12]
EVANGELISTA S. Role of calcitonin gene-related Peptide in gastric mucosal defence and healing[J]. Curr Pharmaceutical Des, 2009, 15(30): 3571-3576.
[13]
尹优聪, 李元建. 降钙素基因相关肽介导的药物药理学效应[J]. 中国药理学与毒理学杂志, 2017, 31(1): 112-118.
[14]
CLARIVATE ANALYTICS. Clarivate Analytics Cortellis数据库[EB/OL]. (2019-12-24) [2020-01-10]. https://www.cortellis.com/.
[15]
ALLERGAN. UBRELVY (ubrogepant): US prescribing information[EB/OL]. (2019-12-23) [2020-01-13]. http://www.fda.gov.
[16]
VOSS T, LIPTON RB, DODICK DW, et al. A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine[J]. Cephalalgia, 2016, 36(9): 887-898.
[17]
GOADSBY PJ, TEPPER SJ, WATKINS PB, et al. Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults[J]. Cephalalgia, 2019, 39(14): 1753-1761.
[18]
AILANI J, LIPTON RB, HUTCHINSON S, et al. Long-term safety evaluation of ubrogepant for the acute treatment of migraine: phase 3, randomized, 52-week extension trial[J]. Headache: J Head Face Pain, 2020, 60(1): 141-152.
[19]
JAKATE A, BOINPALLY R, BUTLER M, et al. Evaluation of the pharmacokinetic interaction and safety of ubrogepant coadministered with acetaminophen or nonsteroidal anti-inflammatory drugs. A randomized trial[J]. Cephalalgia Reps, 2020, 3: 1-3.
[20]
SCOTT LJ. Ubrogepant: first approval[J]. Drugs, 2020, 80(3): 323-328.
[21]
DODICK DW, LIPTON RB, AILANI J, et al. Ubrogepant for the treatment of migraine[J]. N Engl J Med, 2019, 381(23): 2230-2241.
[22]
LIPTON RB, DODICK DW, AILANI J, et al. Effect of ubrogepant vs placebo on pain and the most bothersome associated symptom in the acute treatment of migraine: the ACHIEVE II randomized clinical trial[J]. J Am Med Assoc, 2019, 322(19): 1887-1898.
2021年第30卷第22期
PDF下载
22
1
引用本文
BibTeX
文章信息
  • 首发时间:2026-10-28
  • 出版时间:2021-11-30
补充材料
相关文章
文章信息
作者
出版历史
  • 录用日期:2021-01-14
基金
作者信息
    1湖北中医药大学药学院,武汉 430065
    2北京巴瑞医疗器械有限公司,北京 100176

通讯作者:

洪怡,女,博士,副教授,主要从事药物制剂新技术与新药研发。E-mail:。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgxyzz/CN/1322125562760507426
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏